Clinical trial
Ensure Cardiac Resynchronization Therapy Study
NCT00291564 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ensure Cardiac Resynchronization Therapy Study
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2004
- Completion date
- February 28, 2006
- Enrollment
- 430
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.